Comparison of Effects of Smoking and Smokeless Tobacco “Maras Powder” Use on Humoral Immune System Parameters

Aral, Murat; Ekerbicer, Hasan Cetin; Celik, Mustafa; Ciragil, Pınar; Gul, Mustafa

doi:https://doi.org/10.1155/MI/2006/85019

Mediators of Inflammation

On this page

Abstract References Copyright Related Articles

Research Communication | Open Access

Volume 2006 | Article ID 085019 | https://doi.org/10.1155/MI/2006/85019

Comparison of Effects of Smoking and Smokeless Tobacco “Maras Powder” Use on Humoral Immune System Parameters

Murat Aral,¹Hasan Cetin Ekerbicer,²Mustafa Celik,³Pınar Ciragil,¹and Mustafa Gul¹

Received26 Nov 2005

Revised08 Feb 2006

Accepted14 Feb 2006

Published19 Mar 2006

Abstract

Background. The aim of this study is to assess the impacts of “Maras powder” and cigarette smoking on the parameters of the humoral immune system. Material and Methods. One hundred seventy seven subjects were included in the study. The IgA, IgG, IgM, C3 and C4 levels were detected via nephelometric method. Results. In1.4% of the control group IgM levels were below normal where it was 10.8% and 18.6% in Maras powder group and in cigarette smoking group respectively. The IgM levels of both groups were significantly lower compared to the control group (P<.05). Nonetheless, the IgE levels of Maras powder group and smoking group were found to be remarkably higher compared to the control group (P<.01). Conclusion. Effects of Maras powder on humoral immune response were found to be similar to that of smoking.

References

A Erenmemisoglu, Y Tekol, M Kartal, and S Kurucu, “The use of a smokeless tobacco in our country “Maras powder”,” in Proceedings of the 2nd International Symposium of Pharmaceutical Sciences, Ankara, Turkey, June 1991.
View at: Google Scholar
Y Ozkul, H Donmez, A Erenmemisoglu, H Demirtas, and N Imamoglu, “Induction of micronuclei by smokeless tobacco on buccal mucosa cells of habitual users,” Mutagenesis, vol. 12, no. 4, pp. 285–287, 1997.
View at: Google Scholar
M A Buyukbese, N Koksal, A Guven, and A Cetinkaya, “Effects of smokeless tobacco “Maras powder” use on respiratory functions,” The Tohoku Journal of Experimental Medicine, vol. 204, no. 3, pp. 173–178, 2004.
View at: Google Scholar
P Lazarus, A M Idris, J Kim, A Calcagnotto, and D Hoffmann, “P53 mutations in head and neck squamous cell carcinomas from Sudanese snuff (toombak) users,” Cancer Detection and Prevention, vol. 20, no. 4, pp. 270–278, 1996.
View at: Google Scholar
S E Murphy, S G Carmella, A M Idris, and D Hoffmann, “Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers,” Cancer Epidemiology, Biomarkers & Prevention, vol. 3, no. 5, pp. 423–428, 1994.
View at: Google Scholar
S N Goud, L Zhang, and A M Kaplan, “Immunostimulatory potential of smokeless tobacco extract in in vitro cultures of murine lymphoid tissues,” Immunopharmacology, vol. 25, no. 2, pp. 95–105, 1993.
View at: Google Scholar
M L Sopori and W Kozak, “Immunomodulatory effects of cigarette smoke,” Journal of Neuroimmunology, vol. 83, no. 1-2, pp. 148–156, 1998.
View at: Google Scholar
P G Holt, “Immune and inflammatory function in cigarette smokers,” Thorax, vol. 42, no. 4, pp. 241–249, 1987.
View at: Google Scholar
A Gulsvik and M K Fagerhoi, “Smoking and immunoglobulin levels,” Lancet, vol. 1, no. 8113, p. 449, 1979.
View at: Google Scholar
D J Tollerud, J W Clark, L M Brown et al., “Association of cigarette smoking with decreased numbers of circulating natural killer cells,” The American Review of Respiratory Disease, vol. 139, no. 1, pp. 194–198, 1989.
View at: Google Scholar
D J Tollerud, J W Clark, L M Brown et al., “The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians,” The American Review of Respiratory Disease, vol. 139, no. 6, pp. 1446–1451, 1989.
View at: Google Scholar
C E Buckley and F C Dorsey, “Serum immunoglobulin levels throughout the life-span of healthy man,” Annals of Internal Medicine, vol. 75, no. 4, pp. 673–682, 1971.
View at: Google Scholar
D J Tollerud, J W Clark, L M Brown et al., “The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers,” Journal of Clinical Immunology, vol. 9, no. 3, pp. 214–222, 1989.
View at: Google Scholar
L G Miller, G Goldstein, M Murphy, and L C Ginns, “Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry,” Chest, vol. 82, no. 5, pp. 526–529, 1982.
View at: Google Scholar
M L Larramendy and S Knuutila, “Increased frequency of micronuclei in B and T8 lymphocytes from smokers,” Mutation Research, vol. 259, no. 2, pp. 189–195, 1991.
View at: Google Scholar
R A Lindemann and N H Park, “The effects of benzo(a)pyrene, nicotine, and tobacco-specific N-nitrosamines on the generation of human lymphokine-activated killer cells,” Archives of Oral Biology, vol. 34, no. 4, pp. 283–287, 1989.
View at: Google Scholar
P Moszczynski, Z Zabinski, P Jr Moszczynski, J Rutowski, S Slowinski, and Z Tabarowski, “Immunological findings in cigarette smokers,” Toxicology Letters, vol. 118, no. 3, pp. 121–127, 2001.
View at: Google Scholar
J W Gerrard, D C Heiner, C G Ko, J Mink, A Meyers, and J A Dosman, “Immunoglobulin levels in smokers and non-smokers,” Annals of Allergy, vol. 44, no. 5, pp. 261–262, 1980.
View at: Google Scholar
P Andersen, O F Pedersen, B Bach, and G J Bonde, “Serum antibodies and immunoglobulins in smokers and nonsmokers,” Clinical and Experimental Immunology, vol. 47, no. 2, pp. 467–473, 1982.
View at: Google Scholar
B Burrows, M Halonen, M D Lebowitz, R J Knudson, and R A Barbee, “The relationship of serum immunoglobulin E, allergy skin tests, and smoking to respiratory disorders,” The Journal of Allergy and Clinical Immunology, vol. 70, no. 3, pp. 199–204, 1982.
View at: Google Scholar
F Saitoh, M Noma, and N Sawashima, “The alkaloids contents of sixty nicotiana species,” Phytochem, vol. 24, pp. 477–480, 1985.
View at: Google Scholar
I Cok and R Ozturk, “Urinary cotinine levels of smokeless tobacco (Maras powder) users,” Human & Experimental Toxicology, vol. 19, no. 11, pp. 650–655, 2000.
View at: Google Scholar
R A Lindemann and N H Park, “Inhibition of human lymphokine-activated killer activity by smokeless tobacco (snuff) extract,” Archives of Oral Biology, vol. 33, no. 5, pp. 317–321, 1988.
View at: Google Scholar

Copyright

Copyright © 2006 Murat Aral et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation Order printed copies

Views

451

Downloads

946

Citations